Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events*
暂无分享,去创建一个
Ose | Aul | P. Aul | B. E. | Ulie | R. M. | Idker | Ader | Ifai | Ynda | Uring | R. Ose | J. Ulie | E. B. Uring | M. R. Idker | N. Ader | R. Ifai | L. Ynda | Ancy R C Ook | S. A. Bstract | P. Aul
[1] J. Hanley,et al. The meaning and use of the area under a receiver operating characteristic (ROC) curve. , 1982, Radiology.
[2] P. Ridker,et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. , 1997, The New England journal of medicine.
[3] L H Kuller,et al. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[4] Murray Wm. Inflammation, aspirin, and the risk of cardiovascular disease. , 1997 .
[5] D. Levy,et al. Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.
[6] R J Glynn,et al. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. , 1998, Circulation.
[7] J. Manson,et al. Hormone replacement therapy and increased plasma concentration of C-reactive protein. , 1999, Circulation.
[8] R. Ross. Atherosclerosis is an inflammatory disease , 1999 .
[9] E. Barrett-Connor,et al. Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study. , 1999, Circulation.
[10] A. Döring,et al. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. , 1999, Circulation.
[11] P. Ridker,et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. , 2000, The New England journal of medicine.
[12] E. Ford,et al. Serum C-reactive protein and self-reported stroke: findings from the Third National Health and Nutrition Examination Survey. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[13] D. Strachan,et al. C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men. , 2000, European heart journal.
[14] J. Danesh,et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses , 2000, BMJ : British Medical Journal.
[15] Natalia S. Rost,et al. Plasma Concentration of C-Reactive Protein and Risk of Ischemic Stroke and Transient Ischemic Attack: The Framingham Study , 2001, Stroke.
[16] P. Ridker,et al. Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults. , 2001, Clinical chemistry.
[17] N Rifai,et al. Evaluation of nine automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Part 2. , 2001, Clinical chemistry.
[18] P. Ridker. Should statin therapy be considered for patients with elevated C-reactive protein? The need for a definitive clinical trial. , 2001, European heart journal.
[19] R B D'Agostino,et al. Cardiovascular Risk Assessment Based on US Cohort Studies: Findings From a National Heart, Lung, and Blood Institute Workshop , 2001, Circulation.
[20] Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. , 2001, The New England journal of medicine.
[21] N Rifai,et al. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. , 2001, JAMA.
[22] J. Mckenney,et al. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.
[23] J. Manson,et al. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study. , 2002, JAMA.
[24] P. Libby,et al. Inflammation and Atherosclerosis , 2002, Circulation.
[25] Paul M. Ridker,et al. Prospective Study of C-Reactive Protein, Homocysteine, and Plasma Lipid Levels as Predictors of Sudden Cardiac Death , 2002, Circulation.
[26] J. Manson,et al. Is C-Reactive Protein Specific for Vascular Disease in Women? , 2002, Annals of Internal Medicine.
[27] A. Exley,et al. Widespread coronary inflammation in unstable angina. , 2003, The New England journal of medicine.